• #LGM Pharma is a Stavudine CAS# 3056-17-5 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 3056-17-5
  • AHFC code: 08:18.08.20
  • Synonyms: 2',3'-Didehydro-3'-deoxythimidine 3'-Deoxy-2'-thymidinene Estavudina [INN-Spanish] Sanilvudine Stavudine [Usan:Ban:Inn] Stavudinum [INN-Latin] STV
  • ATC Code: J05AF04
  • Chemical Formula: C11H28Al8O51S8
  • Molecular Weight: 224.2133
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB00649 (APRD00440)
  • SMILES: CC1=CN([C,,H]2O[C,H](CO)C=C2)C(=O)NC1=O
  • PubChem: 18283
  • IUPAC: 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

Additional Details

For the treatment of human immunovirus (HIV) infections.
Stavudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Stavudine is phosphorylated to active metabolites that compete for incorporation into viral DNA. They inhibit the HIV reverse transcriptase enzyme competitively and act as a chain terminator of DNA synthesis. The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.
Mode of Action:
Stavudine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA.
Phosphorylated intracellularly to stavudine triphosphate, the active substrate for HIV-reverse transcriptase.
Side effects include peripheral neuropathy tingling, burning, numbness, or pain in the hands or feet), fatal lactic acidosis has been reported in patients treated with stavudine (ZERIT) in combination with other antiretroviral agents, severe liver enlargement, inflammation (pain and swelling) of the liver, and liver failure.
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization


  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials


Related YouTube Videos